Atrás
Rango del Día
$113.00
$118.64
Rango de 52 Semanas
$18.23
$151.18
Volumen
275,035
Promedio 50D / 200D
$103.28
/
$71.39
Cierre Anterior
$117.04
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -78.9 | 0.3 |
| P/B | 22.0 | 2.9 |
| ROE % | -59.4 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$203.92
+75.4%
Low: $143.00
High: $255.00
EPS Futuro
-$3.88
Ingresos Est.
27000
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2029 |
$7.28
$7.28 – $7.28
|
310 M | 4 |
| FY2028 |
-$0.74
-$7.04 – $11.06
|
130 M | 10 |
| FY2027 |
-$4.99
-$9.33 – -$2.66
|
25 M | 11 |
Puntos Clave
Earnings declined -193.27% over the past year
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -10.84M
PEG of 0.01 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-193.27%
FCF Growth (3Y)N/A
Calidad
Return on Equity
-59.37%
ROIC-16.89%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.00
Current Ratio7.33
Interest Coverage-3.27
Valoración
P/E Ratio
-78.92
P/B Ratio21.98
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | -193.27% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -17.43M |
| ROE | -59.37% | ROA | -19.76% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -10.84M |
| ROIC | -16.89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 7.33 |
| Interest Coverage | -3.27 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -78.92 | P/B Ratio | 21.98 |
| P/S Ratio | N/A | PEG Ratio | 0.01 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.38B | Enterprise Value | 1.29B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 25.90M | 31.42M |
| Net Income | -17.43M | 18.69M | -33.28M | -45.74M |
| EPS (Diluted) | -7.83 | 14.74 | -29.61 | -56.69 |
| Gross Profit | 0.0 | 0.0 | 23.12M | 29.05M |
| Operating Income | -14.10M | -11.87M | -43.47M | -51.83M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 88.23M | 7.55M | 16.52M | 153.56M | 105.01M |
| Total Liabilities | 25.63M | 11.43M | 39.70M | 102.81M | 73.98M |
| Shareholders' Equity | 62.61M | -3.88M | -23.17M | 50.76M | 31.03M |
| Total Debt | 0.0 | 0.0 | 0.0 | 14.89M | 16.96M |
| Cash & Equivalents | 83.60M | 7.35M | 16.05M | 117.76M | 70.44M |
| Current Assets | 88.23M | 7.55M | 16.52M | 127.63M | 75.72M |
| Current Liabilities | 12.04M | 2.36M | 5.78M | 50.56M | 22.15M |